Azamian Bobak R.
Insider CIK 1827672 · TARS President/CEO and Board Chair, Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TARS Tarsus Pharmaceuticals, In | S Sale | 2026-09-04 | 2026-09-09 | 7,100 | $90.27 | $640.9K | 830,891 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2026-09-04 | 2026-09-09 | 2,900 | $91.27 | $264.7K | 827,991 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2026-09-04 | 2026-09-09 | 2,900 | $91.27 | $264.7K | 827,991 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2026-09-04 | 2026-09-09 | 7,100 | $90.27 | $640.9K | 830,891 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2026-09-02 | 2026-09-03 | 10,000 | $80.06 | $800.6K | 837,991 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2026-09-02 | 2026-09-03 | 10,000 | $80.06 | $800.6K | 837,991 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2026-06-17 | 2026-06-22 | 4,582 | $61.24 | $280.6K | 853,409 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2026-06-17 | 2026-06-22 | 5,418 | $61.81 | $334.9K | 847,991 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2026-03-19 | 2026-03-19 | 11,964 | $67.00 | $801.6K | 33,421 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2026-03-18 | 2026-03-19 | 11,667 | $68.71 | $801.6K | 45,385 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2026-03-17 | 2026-03-19 | 10,972 | $69.42 | $761.7K | 57,052 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise deriv | 2026-03-15 | 2026-03-17 | 14,878 | — | $0 | 44,634 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise deriv | 2026-03-15 | 2026-03-17 | 23,121 | — | $0 | 46,243 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise deriv | 2026-03-15 | 2026-03-17 | 16,975 | — | $0 | 16,975 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise deriv | 2026-03-15 | 2026-03-17 | 11,300 | — | $0 | 0 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise | 2026-03-15 | 2026-03-17 | 66,274 | — | $0 | 68,024 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2026-03-05 | 2026-03-09 | 96,723 | — | $0 | 96,723 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2026-03-05 | 2026-03-09 | 60,776 | — | $0 | 60,776 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2025-12-24 | 2025-12-30 | 557 | $83.54 | $46.5K | 857,991 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2025-12-24 | 2025-12-30 | 5,443 | $82.41 | $448.6K | 858,548 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | G Gift | 2025-12-04 | 2025-12-08 | 51,885 | — | $0 | 1,750 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2025-09-24 | 2025-09-26 | 6,000 | $55.37 | $332.2K | 812,106 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2025-08-11 | 2025-08-13 | 6,000 | $50.00 | $300.0K | 818,106 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2025-03-24 | 2025-03-26 | 6,000 | $50.00 | $300.0K | 824,106 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2025-03-20 | 2025-03-20 | 8,534 | $50.11 | $427.6K | 53,635 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2025-03-19 | 2025-03-20 | 8,551 | $47.40 | $405.3K | 62,169 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2025-03-18 | 2025-03-20 | 7,131 | $46.29 | $330.1K | 70,720 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise deriv | 2025-03-15 | 2025-03-18 | 11,299 | — | $0 | 11,300 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise deriv | 2025-03-15 | 2025-03-18 | 23,121 | — | $0 | 69,364 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise deriv | 2025-03-15 | 2025-03-18 | 16,975 | — | $0 | 33,950 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise | 2025-03-15 | 2025-03-18 | 51,395 | — | $0 | 77,851 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2025-03-05 | 2025-03-07 | 59,512 | — | $0 | 59,512 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2025-03-05 | 2025-03-07 | 90,736 | — | $0 | 90,736 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2024-03-18 | 2024-03-19 | 10,415 | $30.60 | $318.7K | 26,456 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise deriv | 2024-03-15 | 2024-03-19 | 16,975 | — | $0 | 50,925 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise deriv | 2024-03-15 | 2024-03-19 | 11,299 | — | $0 | 22,599 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise | 2024-03-15 | 2024-03-19 | 28,274 | — | $0 | 36,871 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2024-03-07 | 2024-03-11 | 136,947 | — | $0 | 136,947 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2024-03-07 | 2024-03-11 | 92,485 | — | $0 | 92,485 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2023-12-27 | 2023-12-29 | 8,000 | $20.22 | $161.8K | 830,106 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2023-12-20 | 2023-12-22 | 30,557 | $20.36 | $622.1K | 838,106 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2023-12-20 | 2023-12-22 | 9,443 | $19.96 | $188.5K | 868,663 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2023-11-15 | 2023-11-17 | 2,896 | $18.01 | $52.2K | 883,210 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2023-11-15 | 2023-11-17 | 200 | $19.28 | $3.9K | 878,106 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2023-11-15 | 2023-11-17 | 4,904 | $18.54 | $90.9K | 878,306 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2023-10-18 | 2023-10-20 | 8,000 | $13.24 | $105.9K | 886,106 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2023-09-20 | 2023-09-22 | 8,000 | $17.21 | $137.7K | 894,106 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2023-08-23 | 2023-08-25 | 8,000 | $17.23 | $137.8K | 902,106 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2023-07-19 | 2023-07-21 | 99,726 | $20.04 | $2.00M | 910,106 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2023-07-19 | 2023-07-21 | 4,174 | $19.28 | $80.5K | 1,009,832 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2023-07-12 | 2023-07-14 | 9,000 | $17.35 | $156.2K | 1,014,006 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2023-06-21 | 2023-06-23 | 8,000 | $18.63 | $149.0K | 1,023,006 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2023-06-14 | 2023-06-16 | 9,000 | $18.58 | $167.2K | 1,031,006 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2023-06-08 | 2023-06-12 | 3,100 | $20.01 | $62.0K | 1,040,006 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2023-05-17 | 2023-05-19 | 8,000 | $15.90 | $127.2K | 1,043,106 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2023-05-10 | 2023-05-12 | 9,000 | $16.80 | $151.2K | 1,051,106 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2023-05-01 | 2023-05-02 | 5,841 | $15.10 | $88.2K | 1,060,106 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2023-04-28 | 2023-05-02 | 4,278 | $15.13 | $64.7K | 1,065,947 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2023-04-21 | 2023-04-25 | 2,311 | $15.03 | $34.7K | 1,070,225 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2023-04-19 | 2023-04-21 | 8,000 | $13.60 | $108.8K | 1,072,536 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2023-03-23 | 2023-03-23 | 737 | $12.15 | $9.0K | 8,597 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2023-03-22 | 2023-03-23 | 709 | $12.64 | $9.0K | 9,334 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2023-03-21 | 2023-03-23 | 679 | $12.89 | $8.8K | 10,043 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2023-03-20 | 2023-03-21 | 741 | $12.61 | $9.3K | 10,722 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2023-03-17 | 2023-03-21 | 795 | $13.28 | $10.6K | 11,463 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2023-03-16 | 2023-03-17 | 791 | $13.43 | $10.6K | 12,258 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise deriv | 2023-03-15 | 2023-03-17 | 11,299 | — | $0 | 33,898 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise | 2023-03-15 | 2023-03-17 | 11,299 | — | $0 | 13,049 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2023-03-15 | 2023-03-17 | 8,000 | $13.79 | $110.3K | 1,080,536 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2023-03-09 | 2023-03-10 | 717 | $15.01 | $10.8K | 1,088,536 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2023-03-08 | 2023-03-10 | 100,242 | — | $0 | 100,242 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2023-03-08 | 2023-03-10 | 67,900 | — | $0 | 67,900 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2023-03-08 | 2023-03-10 | 4,853 | $15.02 | $72.9K | 1,089,253 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2023-02-15 | 2023-02-17 | 8,000 | $15.28 | $122.2K | 1,094,106 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2023-02-08 | 2023-02-10 | 9,000 | $15.14 | $136.3K | 1,102,106 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2023-01-23 | 2023-01-25 | 4,856 | $15.45 | $75.0K | 1,111,106 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2023-01-20 | 2023-01-20 | 240 | $15.00 | $3.6K | 1,116,373 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2023-01-18 | 2023-01-20 | 8,000 | $14.56 | $116.5K | 1,116,613 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2023-01-11 | 2023-01-13 | 3,904 | $15.11 | $59.0K | 1,124,613 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2023-01-10 | 2023-01-11 | 905 | $15.17 | $13.7K | 1,128,517 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2023-01-09 | 2023-01-11 | 729 | $15.15 | $11.0K | 1,129,422 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2023-01-06 | 2023-01-24 | 411 | $15.00 | $6.2K | 1,129,740 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2022-12-21 | 2022-12-22 | 8,000 | $14.57 | $116.6K | 1,130,151 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2022-12-16 | 2022-12-20 | 535 | $15.01 | $8.0K | 1,138,151 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2022-12-14 | 2022-12-16 | 6,420 | $15.08 | $96.8K | 1,138,686 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2022-11-16 | 2022-11-18 | 745 | $17.31 | $12.9K | 1,145,106 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2022-11-16 | 2022-11-18 | 7,255 | $16.81 | $122.0K | 1,145,851 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2022-11-09 | 2022-11-14 | 9,000 | $17.87 | $160.8K | 1,153,106 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2022-10-19 | 2022-10-21 | 7,900 | $16.91 | $133.6K | 1,162,206 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2022-10-19 | 2022-10-21 | 100 | $17.60 | $1.8K | 1,162,106 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2022-10-12 | 2022-10-14 | 2,821 | $16.24 | $45.8K | 1,170,106 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2022-10-12 | 2022-10-14 | 6,179 | $15.76 | $97.4K | 1,172,927 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2022-09-21 | 2022-09-23 | 100 | $17.05 | $1.7K | 1,179,106 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2022-09-21 | 2022-09-23 | 7,900 | $16.30 | $128.8K | 1,179,206 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2022-09-14 | 2022-09-16 | 9,000 | $16.01 | $144.1K | 1,187,106 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2022-08-17 | 2022-08-19 | 736 | $17.44 | $12.8K | 1,196,106 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2022-08-17 | 2022-08-19 | 7,264 | $16.50 | $119.9K | 1,196,842 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2022-03-09 | 2022-03-11 | 154,067 | — | $0 | 154,067 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2022-03-09 | 2022-03-11 | 45,197 | — | $0 | 45,197 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2021-12-01 | 2021-12-03 | 578 | $26.76 | $15.5K | 1,204,106 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2021-12-01 | 2021-12-03 | 2,394 | $23.86 | $57.1K | 1,207,545 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2021-12-01 | 2021-12-03 | 2,101 | $24.70 | $51.9K | 1,205,444 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2021-12-01 | 2021-12-03 | 760 | $25.90 | $19.7K | 1,204,684 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2021-11-01 | 2021-11-03 | 800 | $28.21 | $22.6K | 1,209,939 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2021-11-01 | 2021-11-03 | 5,033 | $27.76 | $139.7K | 1,210,739 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2021-10-12 | 2021-10-14 | 833 | $25.49 | $21.2K | 1,220,470 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2021-10-12 | 2021-10-14 | 4,698 | $26.44 | $124.2K | 1,215,772 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2021-10-08 | 2021-10-12 | 302 | $25.02 | $7.6K | 1,221,303 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2021-09-01 | 2021-09-03 | 5,733 | $25.23 | $144.6K | 1,221,705 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2021-09-01 | 2021-09-03 | 100 | $26.40 | $2.6K | 1,221,605 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2021-08-11 | 2021-08-12 | 1,917 | $25.07 | $48.1K | 1,227,438 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2021-08-10 | 2021-08-12 | 103 | $25.00 | $2.6K | 1,229,355 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2021-08-09 | 2021-08-10 | 100 | $25.13 | $2.5K | 1,229,458 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2021-08-09 | 2021-08-10 | 727 | $25.00 | $18.2K | 1,229,558 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2021-08-06 | 2021-08-10 | 1,616 | $25.00 | $40.4K | 1,230,285 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2021-08-05 | 2021-08-06 | 1,370 | $25.00 | $34.3K | 1,231,901 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2021-01-07 | 2021-01-08 | 204,998 | — | $0 | 204,998 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | C Conversion deriv | 2020-10-20 | 2020-10-20 | 1,750 | — | $0 | 0 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | C Conversion deriv | 2020-10-20 | 2020-10-20 | 21,575 | — | $0 | 0 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | C Conversion | 2020-10-20 | 2020-10-20 | 1,750 | — | $0 | 1,750 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | C Conversion | 2020-10-20 | 2020-10-20 | 21,575 | — | $0 | 1,233,271 | SEC↗ |